Should you buy soaring growth stock Versarien plc after 100% rise in a week?

Rapidly-doubling growth shares like Versarien plc (LON: VRS) don’t come along very often, so is it time to buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Versarien (LSE: VRS) closed the day at 21.25p on 16 November, yet within a week they’d more than doubled to a high of 44.5p — at close on Thursday the price had dropped back to 39.1p, but that’s still an 84% gain.

So what is Versarien, and what’s going on?

The company, which describes itself as an “advanced materials engineering group,” produces something called Nanene — a particular type of ‘nano’ graphene. Graphene is claimed to be 200 times stronger than steel — and as it conducts electricity and heat, it has been touted as a replacement for copper wires and for use for circuitry on flexible surfaces.

The stuff sounds like it has great potential, and investor enthusiasm helped create a Versarien share price spike back in April — though that petered out over the subsequent few months.

Versarien is still in its cash-burn days — but the firm’s fundraising round in early November was very successful. So much so that it was more than twice oversubscribed, and was enlarged to raise a total of £2.9m.

Exciting progress

At recent rates of losses that might last around another year-and-a-half, but there’s been a big development that could potentially change all that — on 17 November, the company announced a collaboration with a “global consumer goods company,” and that’s the day the share price commenced its rapid ascent.

We’d already heard, in Versarien’s 3 November, trading update that it was “in advanced negotiations with two of the world’s largest consumer goods groups and anticipates receipt of the first purchase order imminently.” The latest update expanded that to say it “has now started collaborating with one of them to enable both groups to work together on research, development and testing of Versarien’s proprietary Nanene few layer graphene nano-platelets in polymer structures.”

As part of that, the as-yet-unidentified new partner has placed its first Nanene purchase order and will use it in polymer structures “primarily for packaging applications, for testing and evaluation, with a view to improving material strength, moisture control and recyclability.”

Negotiations are also in progress, we are told, with “a number of other multinational companies” with a view to further collaboration and commercialisation of the product.

But wait a mo…

This might make you want to rush over to your broker and place an order for Versarien shares — but before you do, you need to be aware of the risks.

Although the global graphene market is predicted to grow from a little over $20m at the end of 2016 to more than $600m by 2025 (and beyond that, who knows — very possibly into billions), the material is proving hard to commercialise and others firms have not been able to turn it into a big money-spinner yet.

And though Versarien’s new partnership deal (especially when coupled with other potential developments) does sound like a significant step forward, there are still many unanswered questions.

Will the commercialisation of the product be successful? How much of the funding for it will each partner contribute? How many ways and by what proportions will future profits be split? How long will it take before large-scale commercialisation becomes a reality? When will Versarien see its first profits? And what further funding (with accompanying dilution) will be needed before that time arrives?

Versarien could be very big, but it’s very risky.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

5 steps to start buying shares with under £500

Learn how this writer would start buying shares with a few hundred pounds in a handful of steps, if he…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

The FTSE 100 offers some great bargains. Is this one?

Our writer digs into one FTSE 100 share that has had a rough 2024 to date, ahead of its interim…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£9,000 of savings? Here’s my 3-step approach to aim for £1,794 in passive income

Christopher Ruane walks through the practical steps he would take to try and turn £9,000 into a sizeable passive income…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

I’d buy 29,412 shares of this UK dividend stock for £150 a month in passive income

Insiders have been buying this dividend stock, which offers an 8.5% yield. Roland Head explains why he’d choose the shares…

Read more »

Red briefcase with the words Budget HM Treasury embossed in gold
Investing Articles

Could the new UK budget spell growth for these 6 FTSE stocks? I think so!

Mark David Hartley considers six UK stocks that could enjoy growth off the back of new measures announced in the…

Read more »

Investing Articles

With a 6.6% yield, is now the right time to add this income stock to my ISA?

Our writer’s looking to boost his Stocks and Shares ISA. With this in mind, he’s debating whether to buy a…

Read more »

Dividend Shares

This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

Read more »

Investing Articles

At 72p, the Vodafone share price looks to be at least 33% undervalued to me

Our writer looks at a number of valuation measures to determine whether the Vodafone share price reflects the fair value…

Read more »